442 related articles for article (PubMed ID: 27540907)
1. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
[TBL] [Abstract][Full Text] [Related]
2. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
[TBL] [Abstract][Full Text] [Related]
3. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
[TBL] [Abstract][Full Text] [Related]
4. EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma.
da Rosa MR; Falcão AS; Fuzii HT; da Silva Kataoka MS; Ribeiro AL; Boccardo E; de Siqueira AS; Jaeger RG; de Jesus Viana Pinheiro J; de Melo Alves Júnior S
Tumour Biol; 2014 Nov; 35(11):11107-20. PubMed ID: 25099616
[TBL] [Abstract][Full Text] [Related]
5. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness.
Zheng X; Jiang F; Katakowski M; Kalkanis SN; Hong X; Zhang X; Zhang ZG; Yang H; Chopp M
Cancer Sci; 2007 May; 98(5):674-84. PubMed ID: 17355261
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
Cancer Sci; 2009 Apr; 100(4):654-62. PubMed ID: 19298600
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
Kang CS; Pu PY; Wang GX; Li YH; Dong L; Wang H
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1503-8. PubMed ID: 15500708
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma.
Ohnishi Y; Inoue H; Furukawa M; Kakudo K; Nozaki M
Oncol Rep; 2012 Apr; 27(4):954-8. PubMed ID: 22209887
[TBL] [Abstract][Full Text] [Related]
11. ADAM17 promotes U87 glioblastoma stem cell migration and invasion.
Chen X; Chen L; Chen J; Hu W; Gao H; Xie B; Wang X; Yin Z; Li S; Wang X
Brain Res; 2013 Nov; 1538():151-8. PubMed ID: 23470260
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression.
Kwiatkowska A; Kijewska M; Lipko M; Hibner U; Kaminska B
Biochim Biophys Acta; 2011 May; 1813(5):655-67. PubMed ID: 21276823
[TBL] [Abstract][Full Text] [Related]
13.
Gwon DH; Lee WY; Shin N; Kim SI; Jeong K; Lee WH; Kim DW; Hong J; Lee SY
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231148
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
Guo Y; He X; Zhang M; Qu Y; Gu C; Ren M; Wang H; Ning W; Li J; Yu C; Zhang H
J Neurooncol; 2020 Apr; 147(2):327-337. PubMed ID: 32170633
[TBL] [Abstract][Full Text] [Related]
15. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
[TBL] [Abstract][Full Text] [Related]
16. [ADAM17 knockdown increases sensitivity of SW480 cells to cetuximad].
Chen Y; Zheng K; Chen Z; Feng H; Fang W; Huang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1366-1371. PubMed ID: 30514687
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus-mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitro.
Li YQ; Liu YS; Ying XW; Zhou HB; Wang Z; Wu SC; Yan JP; Jing YT; Yang Y
Biotechnol Prog; 2018 Jan; 34(1):196-205. PubMed ID: 28960861
[TBL] [Abstract][Full Text] [Related]
18. ADAM17 regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the EGFR/ERK signaling pathway.
Le X; Fan YF
J Plast Surg Hand Surg; 2023; 57(1-6):129-136. PubMed ID: 34978504
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways.
Sun J; Jiang J; Lu K; Chen Q; Tao D; Chen Z
Mol Cell Biochem; 2017 Feb; 426(1-2):17-26. PubMed ID: 27878499
[TBL] [Abstract][Full Text] [Related]
20. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]